Status:
ACTIVE_NOT_RECRUITING
Quality of Life as a Predictor of OS and PFS in Patients With Lung Cancer
Lead Sponsor:
Instituto Nacional de Cancerologia, Columbia
Collaborating Sponsors:
Hospital Universitario San Ignacio
Hospital Pablo Tobón Uribe
Conditions:
Lung Cancers
Lung Cancer, Non-Small Cell
Eligibility:
All Genders
18+ years
Brief Summary
By 2020, lung cancer continues leading the first cause of cancer mortality and the second most common type of cancer in the world. There are limitations to early detection and then more than 60% of pa...
Detailed Description
The validation process of the scale includes the evaluation of internal consistency, content validity, sensitivity to change, test-retest reliability and the data will be analyzed according to the ite...
Eligibility Criteria
Inclusion
- Have a confirmed histologic diagnosis of non-small cell lung cancer
- Advanced stage (III to IV)
- 8 years older
- Voluntary acceptance of participation
Exclusion
- Present cognitive or sensory deficits that make it difficult to process the instruments used in the research
- Metachronous tumor
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT06900283
Start Date
January 1 2021
End Date
December 31 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Cancerologia
Bogota, Cundinamarca, Colombia, 111511